Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-15Clinical Trial Update: Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis [NA]
A pediatric clinical trial investigating exercise intolerance and skeletal muscle bioenergetics in children with deep vein thrombosis and pu…
-
FDA approval · 2024-10-24FDA Approved: HEPARIN SODIUM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for Heparin Sodium, the anticoagulant. The approval updates the product's labeling/indication…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome [NA]
The trial evaluating a novel exercise program to prevent post-thrombotic syndrome in patients with acute deep vein thrombosis has been compl…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Diagnostic Performance of General Practitioners in Compression UltraSound [NA]
A clinical trial update evaluating how well general practitioners diagnose deep vein thrombosis using compression ultrasound. The study stat…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries [NA]
A completed clinical trial assessing bemiparin as thromboprophylaxis after gynecological surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-09-12EMA Authorised: Xarelto (rivaroxaban) — Bayer AG
The European Medicines Agency authorised Xarelto (rivaroxaban) for the prevention of venous thromboembolism in patients undergoing arthropla…
-
FDA approval · 2024-09-11FDA Approved: DABIGATRAN ETEXILATE — Original Application (Major Pharmaceuticals)
The FDA approved an original application for dabigatran etexilate (generic) from Major Pharmaceuticals. It covers indications such as nonval…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Wearable Technology to Reduce Risk of DVT and Increase Patient Compliance [NA]
A completed clinical trial evaluated wearable technology to reduce the risk of deep vein thrombosis and improve patient compliance in orthop…
-
FDA approval · 2024-08-16FDA Approved: DABIGATRAN ETEXILATE — Supplemental Application (Major Pharmaceuticals)
The FDA approved a supplemental application for dabigatran etexilate (generic) submitted by Major Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
This clinical trial update reports on outcomes of patients who survived ICU treatment for COVID-19 in England and Wales.
-
FDA approval · 2024-08-13FDA Approved: DABIGATRAN ETEXILATE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved XLCare Pharmaceuticals' original application for dabigatran etexilate (generic), confirming a generic version of the anticoagul…
-
FDA approval · 2024-08-12FDA Approved: DABIGATRAN ETEXILATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for dabigatran etexilate, a generic anticoagulant. It is used to reduce stroke ri…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: The Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities [NA]
Completed clinical trial from the University of Illinois at Chicago assessing the incidence of perioperative deep vein thrombosis in the low…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism [NA]
A clinical trial update describes a study to alert providers at hospital discharge to consider prescribing rivaroxaban to reduce venous thro…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis
A completed clinical trial update examining the use of mechanical thrombectomy and catheter-directed thrombolysis in patients with deep vein…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
The VTEval Project is a prospective cohort study at Johannes Gutenberg University Mainz to evaluate diagnostics, management strategies, and …
-
FDA approval · 2024-06-14FDA Approved: DABIGATRAN ETEXILATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' Original Application for dabigatan etexilate as a generic version of Pradaxa, an oral anticoagulant in…
-
FDA approval · 2024-05-22FDA Approved: DABIGATRAN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA (ANDA213879) for DABIGATRAN (Dabigatan etexilate), a generic anticoagulant. The approval enables Novadoz Phar…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring Immobilisation
A clinical trial is assessing how consistently different observers apply the TRiP(Cast) score in patients with lower-limb trauma requiring i…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome [Phase 4]
Phase 4 trial update on tinzaparin lead-in to prevent post-thrombotic syndrome in patients with deep vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) [Phase 4]
Phase 4 clinical trial comparing Lovenox 30 mg twice daily versus 40 mg once daily in trauma/surgery patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Compression Hosiery to Avoid Post-Thrombotic Syndrome [NA]
A terminated clinical trial investigated compression hosiery to prevent post-thrombotic syndrome in patients with deep vein thrombosis; resu…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis [Phase 3]
A Phase 3 clinical trial update reports eight-week treatment with a venoactive drug for deep vein thrombosis, focusing on resolution enhance…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma [Phase 2]
Phase 2 clinical trial evaluating weight-based enoxaparin dosing with real-time dose adjustment for orthopaedic trauma; study completed with…
-
FDA approval · 2023-12-15FDA Approved: DABIGATRAN ETEXILATE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for dabigatran etexilate as a generic anticoagulant. The generic will have the same indicat…